Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03805386 · ClinicalTrials.gov registry record · Phase 2
Patient-Directed Postoperative Opioid Prescribing for Gynecologic Surgery
A Phase 2 study, sponsored by Mayo Clinic.
- Completed
- Registry status
- Phase 2
- Development phase
- 65
- Enrollment target
NCT03805386: Completed Phase 2 study, sponsored by Mayo Clinic.
NCT03805386 is a Phase 2 study that has completed, run by Mayo Clinic. The registered enrollment target is 65 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03805386, a Phase 2 study, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 65 participants
- Enrollment target
Study Summary
We would like to evaluate and optimize opioid prescribing after minimally invasive hysterectomy. Currently, our standard prescribing is 150 oral morphine equivalents. However, recent studies show that half of the opioids prescribed are not used. We would like to include the patient in the decision making of the opioid prescribing. We have designed a randomized controlled trial to prescribe standard (150 oral morphine equivalents) or patient directed (less than or equal to 150 oral morphine equivalents) for pain control. We hypothesize that with patient input, there will be a higher utilization of the opioids prescribed. Also, we anticipate a lower number of opioids used overall. This study will help us optimize opioid prescribe and evaluate whether patient input can help in this important measure.
Interventions
- DRUG Physician directed opioid prescribing
- DRUG Patient directed opioid prescribing
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 65 participants |
| Start Date | 2019-01-15 |
| Est. Completion | 2020-04-15 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03805386
The ClinicalTrials.gov registry entry for NCT03805386 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 65 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Physician directed opioid prescribing is the first listed.
NCT03805386 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03805386 about?
NCT03805386 is a clinical study titled "Patient-Directed Postoperative Opioid Prescribing for Gynecologic Surgery". We would like to evaluate and optimize opioid prescribing after minimally invasive hysterectomy. Currently, our standard prescribing is 150 oral morphine equivalents. However, recent studies show that half of the opioids prescribed are not used. We would like to include the patient in the decision m...
What is the current status of trial NCT03805386?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 65 participants. The study started on 2019-01-15. Estimated completion is 2020-04-15.
What interventions are being tested in trial NCT03805386?
The interventions under investigation include: Physician directed opioid prescribing (DRUG), Patient directed opioid prescribing (DRUG).
Who is sponsoring clinical trial NCT03805386?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.